Cryo-Cell International, Inc. (NYSEAM: CCEL)
Health Care · Health Care Providers & Services · US
$4.54
+4.13% today · -1.5% 1Y
Cryo-Cell International, Inc. (NYSEAM: CCEL) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $35.15M and employs 74 people.
Over the last twelve months the share price has lost 1.5%, trading between 2.72 and 4.90.
Tweenvest scores Cryo-Cell International, Inc. across four factors: quality 61/100, value 54/100, growth 12/100. Its strongest factor is quality.
CCEL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $35.15M
- Revenue (TTM)
- $31.13M
- P/E
- —
- EPS
- -0.24
- Dividend yield
- —
- Beta (5Y)
- 0.59
- 52-week high
- $4.90
- 52-week low
- $2.72
- Avg volume (3M)
- —
- Shares outstanding
- 8.06M
- Employees
- 74
- Next earnings
- —
About Cryo-Cell International, Inc.
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
- ISIN
- US2288951088
- Founded
- 1989
- Listed since
- Apr 4, 1994
- Exchange
- NYSE American LLC
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Human Health Holdings LimitedSEHK: 1419 | $36.76M | HK$0.76 | -2.56% |
| LEOCLAN Co.,Ltd.TSE: 7681 | $36.50M | ¥976.00 | -0.81% |
| Care Twentyone CorporationTSE: 2373 | $36.30M | ¥425.00 | -4.28% |
| Sinco Pharmaceuticals Holdings LimitedSEHK: 6833 | $35.75M | HK$0.14 | -1.43% |
| Excelsior Biopharma Inc.TPEX: 6496 | $34.74M | NT$23.85 | -0.42% |
| PT UBC Medical Indonesia TbkIDX: LABS | $34.66M | Rp157.00 | +7.53% |
| Cengild Medical BerhadKLSE: CENGILD | $34.66M | RM0.17 | -12.82% |
| Yunkang Group LimitedSEHK: 2325 | $34.31M | HK$0.46 | -1.08% |
Figures last refreshed Oct 11, 2026.